Log2(fold change) for ccrcc2_3 <i>vs</i> ccrcc1_4 for every miRNA, as well as hazard ratios for OS after diagnosis, OS since metastasis and time to metastasis, progression free survival on first-line sunitinib or pazopanib and Mann-Whitney test for response <i>versus</i> progressive disease.
收藏NIAID Data Ecosystem2026-03-12 收录
数据链接：
官方服务：
资源简介：
(XLSX)
创建时间：
2020-09-11
相关数据集
暂无相关数据集
